Jean‐Paul Vernant
- Hematology top 0.5%
- Hematopoietic Stem Cell Transplantation 30
- Chronic Myeloid Leukemia Treatments 15
- Acute Myeloid Leukemia Research 13
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research 7
- Immunology top 2%
- T-cell and B-cell Immunology 13
- Immune Cell Function and Interaction 11
- Transplantation top 5%
-
- Acute Lymphoblastic Leukemia research 14
-
- Lymphoma Diagnosis and Treatment 11
- Co-authors
- Catherine CordonnierAgnès BuzynNathalie DhédinMathieu KuentzNorbert IfrahXavier ThomasHervé DombretElizabeth Macintyre
- Cited by
- HematologyGeneticsImmunology
- Journals
- Journal of Clinical Oncology (5 papers)Blood (26 papers)The Journal of Immunology (1 paper)
- Partner nations
- FranceSwitzerlandBelgium
In The Last Decade
Jean‐Paul Vernant
81 papers receiving 3.9k citations
Peers
Comparison fields: 5 of 100
- Hematology 1.9k
- Genetics 721
- Immunology 984
- Transplantation 104
- Public Health, Environmental and Occupational Health 1.1k
Countries citing papers authored by Jean‐Paul Vernant
This map shows the geographic impact of Jean‐Paul Vernant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Paul Vernant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Paul Vernant more than expected).
Fields of papers citing papers by Jean‐Paul Vernant
This network shows the impact of papers produced by Jean‐Paul Vernant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Paul Vernant. The network helps show where Jean‐Paul Vernant may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jean‐Paul Vernant, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 21 | |
| 2 | 2012 | 106 | |
| 3 | 2010 | 6 | |
| 4 | 2010 | 4 | |
| 5 | 2010 | 24 | |
| 6 | 2009 | 30 | |
| 7 | 2008 | 208 | |
| 8 | 2008 | 38 | |
| 9 | 2007 | 16 | |
| 10 | 2006 | 189 | |
| 11 | 2006 | 315 | |
| 12 | 2006 | 234 | |
| 13 | 2005 | 13 | |
| 14 | [Treatment of malignant non-Hodgkin's lymphoma. Economic impact of rituximab (Mabthera) versus conventional chemotherapy]. | 2003 | 2 |
| 15 | Purpura thrombotique thrombocytopénique : principes thérapeutiques actuels | 2002 | 1 |
| 16 | 2001 | 8 | |
| 17 | 1997 | 17 | |
| 18 | 1995 | 21 | |
| 19 | 1990 | 66 | |
| 20 | 1988 | 53 |
About Jean‐Paul Vernant
Jean‐Paul Vernant is a scholar working on Hematology, Genetics and Immunology, having authored 85 papers that have together received 4.0k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (30 papers), Chronic Myeloid Leukemia Treatments (15 papers), Acute Lymphoblastic Leukemia research (14 papers), Acute Myeloid Leukemia Research (13 papers), T-cell and B-cell Immunology (13 papers), Immune Cell Function and Interaction (11 papers), Lymphoma Diagnosis and Treatment (11 papers) and Chronic Lymphocytic Leukemia Research (7 papers). The work is most often cited by research in Hematology (1.9k citations), Genetics (721 citations) and Immunology (984 citations). Jean‐Paul Vernant has collaborated with scholars based in France, Switzerland and Belgium. Frequent co-authors include Catherine Cordonnier, Agnès Buzyn, Nathalie Dhédin, Mathieu Kuentz, Norbert Ifrah, Xavier Thomas, Hervé Dombret, Elizabeth Macintyre, Françoise Huguet and Yves Chalandon. Their work appears in journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.